Z-2185-2018 Class II Terminated
FDA device recall Z-2185-2018 was initiated by Roche Diabetes Care, Inc. on May 7, 2018 and is designated Class II. Reason for recall: The recalling firm identified four US lots of test strips out of specification. Affected strips show increased potential for strip errors prior to applying blood, strips not detected once inserted, or… The recall status is terminated (terminated January 16, 2020). Affected quantity: 295, 248.
Recall Details
- Product Type
- Devices
- Report Date
- June 20, 2018
- Initiation Date
- May 7, 2018
- Termination Date
- January 16, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 295, 248
Product Description
Reason for Recall
Distribution Pattern
Worldwide Distribution - US Nationwide distribution. Foreign distribution to Argentina Armenia Australia Austria Azerbaijan Bahamas Bahrain Barbados Belgium Brazil Bulgaria Canada Chile China Colombia Costa Rica Denmark Dominican Republic El Salvador Finland Georgia Germany Ghana Greece Guatemala Honduras Hong Kong (SAR China) Hungary India Indonesia Israel Italy Jamaica Japan Jordan Ireland Kenya Korea Kuwait Lebanon Lithuania Luxembourg Malaysia Malta Mexico Myanmar Netherlands New Zealand Norway Oman Pakistan Philippines Poland Russian Federation New Zealand Saudi Arabia Serbia Singapore Slovenia South Africa Spain Sweden Switzerland Taiwan (Republic of China), Thailand, United Arab Emirates, United Kingdom, Vietnam, Portugal"